Spironolactone may be safe to treat female pattern hair loss in breast cancer survivo
Spironolactone is not associated with increased risk of female breast cancer recurrence, according to research from the George Washington University Department of Dermatology.
More... |
All times are GMT -7. The time now is 04:03 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021